Human B-cells can form Hetero-aggregates with Blood Platelets: A Novel Insight into Adaptive Immunity Regulation in...

Area of Science:

• Immunology
• Neuroscience
• Hematology

Background:

• Multiple sclerosis (MS) is a chronic autoimmune disease impacting the central nervous system.
• Inflammation and neurodegeneration are key pathological features of MS.
• Understanding immune cell interactions is crucial for MS pathogenesis.

Purpose of the Study:

• To investigate the interactions between blood platelets and leukocytes in MS.
• To analyze the role of platelet-leukocyte aggregates (PLAs) in modulating immune responses in MS.
• To differentiate these interactions in relapsing-remitting MS (RRMS) and secondary progressive MS (SPMS) compared to healthy controls (HC).

Main Methods:

• Flow cytometry to assess platelet activation markers (PAC-1, CD62P, GPVI) and platelet-lymphocyte aggregates (PLAs-Ly).
• Immunophenotyping and confocal microscopy to visualize and quantify PLAs, particularly those involving B-cells (PLAs-LyB).
• Analysis of the CD40-CD40L pathway in platelet-lymphocyte interactions.

Main Results:

• Significantly increased leukocyte migration towards platelets observed in MS patients.
• Elevated expression of platelet activation markers (PAC-1, CD62P) in RRMS and SPMS; higher GPVI in SPMS.
• Increased formation of PLAs-Ly, predominantly involving B-cells, across both MS phenotypes, with significant CD40L-CD40 correlations on B-cells in SPMS.

Conclusions:

• Platelet-leukocyte interactions, especially platelet-B cell cross-talk via the CD40-CD40L pathway, are significantly altered in MS.
• These interactions, particularly PLAs-LyB formation, may play a critical role in the immune response and pathogenesis of MS, especially in progressive forms.
• The findings highlight novel therapeutic targets for modulating immune responses in multiple sclerosis.